as 09-06-2024 4:00pm EST
Stocks
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
Founded: | 2014 | Country: | United States |
Employees: | N/A | City: | THE WOODLANDS |
Market Cap: | 17.9M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 600.1K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.07 | EPS Growth: | N/A |
52 Week Low/High: | $0.51 - $7.60 | Next Earning Date: | 11-02-2024 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AMIX Breaking Stock News: Dive into AMIX Ticker-Specific Updates for Smart Investing
GlobeNewswire
11 days ago
GlobeNewswire
17 days ago
GlobeNewswire
25 days ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
GlobeNewswire
2 months ago
GlobeNewswire
2 months ago
ACCESSWIRE
2 months ago
The information presented on this page, "AMIX AUTONOMIX MEDICAL INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.